Seoul, M5CIK 17100655 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
7 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Arcellx Inc | 223.5K | $14.57M | 63.9% | −824.1K | Reduced |
| 2 | Rallybio Corp | 754.7K | $4.14M | 18.2% | 0 | Held |
| 3 | Kymera Therapeutics Inc | 19.6K | $1.53M | 6.7% | −437.4K | Reduced |
| 4 | Seer Inc |
| 816.4K |
| $1.49M |
| 6.6% |
| 0 |
| Held |
| 5 | Xilio Therapeutics Inc | 667.7K | $427.5K | 1.9% | 0 | Held |
| 6 | Rapt Therapeutics Inc | 12.4K | $421.2K | 1.8% | 0 | Held |
| 7 | Sutro Biopharma Inc | 17.5K | $202.5K | 0.9% | −157.5K | Reduced |